Overexpression of ECM1 contributes to migration and invasion in cholangiocarcinoma cell

Neoplasma

Volumn 59, Issue 4, 2012, Pages 409-415

  Xiong, G P ^a,b   Zhang, J X ^b   Gu, S P ^c   Wu, Y B ^a   Liu, J F ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

^b Department of Hepatobiliary Surgery Liver Disease Center of Xiamen Traditional Hospital   (China)

^c Minimally invasive surgery department of shishi city hospital   (China)

Author keywords

Akt NF B; Cholangiocarcinoma; Extracellular matrix protein 1; Invasion; Migration

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CELL PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; EXTRACELLULAR MATRIX PROTEIN 1; GELATINASE A; GELATINASE B; I KAPPA B KINASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MATRIGEL; UNCLASSIFIED DRUG; ECM1 PROTEIN, HUMAN; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SCLEROPROTEIN;

ADULT; ARTICLE; BILE DUCT CARCINOMA; CANCER PROGNOSIS; CELL INVASION; CELL MIGRATION; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; MIDDLE AGED; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR DIFFERENTIATION; WESTERN BLOTTING; WOUND HEALING; APOPTOSIS; BILE DUCT TUMOR; CANCER INVASION; CELL ADHESION; CELL MOTION; CELL PROLIFERATION; ENZYME IMMUNOASSAY; GENETICS; INTRAHEPATIC BILE DUCT; METABOLISM; MORTALITY; PATHOLOGY; SIGNAL TRANSDUCTION; SURVIVAL RATE; TUMOR CELL CULTURE;

APOPTOSIS; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; BLOTTING, WESTERN; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; CHOLANGIOCARCINOMA; EXTRACELLULAR MATRIX PROTEINS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NF-KAPPA B; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; SURVIVAL RATE; TUMOR CELLS, CULTURED; WOUND HEALING;

EID: 84864560314     PISSN: 00282685     EISSN: 13384317     Source Type: Journal    
DOI: 10.4149/neo_2012_053     Document Type: Article

References (20)

1. ALJIFFRY M, WALSH MJ, MOLINARI M. Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009. World J Gastroenterol. 2009; 15: 4240-4262. http://dx.doi.org/10.3748/wjg.15.4240
2. SHEN FZ, ZHANG BY, FENG YJ, JIA ZX, AN B, et al. Current research in perineural invasion of cholangiocarcinoma. Journal of Experimental & Clinical Cancer Research. 2010; 29: 24.
3. HASSID VJ, ORLANDO FA, AWAD ZT, TAN D, KHOURY T, et al. Genetic and molecular abnormalities in cholangiocarcinogenesis. Anticancer Res. 2009; 29: 1151-6.
4. HAN Z, LIN GJ, CHI FL, WANG SY, HUANG JM, et al. The relationship between the extracellular matrix and the angiogenesis and metastasis of laryngeal carcinoma. ORL J Otorhinolaryngol Relat Spec. 2008; 70: 352-8. http://dx.doi.org/10.1159/000163030
5. MATHIEU E, MEHEUS L, RAYMACKERS J, MERREGAETT J: Characterization of the stromal osteogenic cell line MN7: identification of secreted MN7 proteins using two-dimensional polyacrylamide gel electrophoresis, Western blotting and microsequencing. J Bone Miner Res. 1994; 9: 903-913. http://dx.doi.org/10.1002/jbmr.5650090616
6. HAN Z, NI J, SMITS P, UNDERHILL CB, XIE B, et al. Extracellular matrix protein 1 (ECM1) has angiogenic properties and is expressed by breast tumor cells. FASEB J. 2001; 15: 988-94. http://dx.doi.org/10.1096/fj.99-0934com
7. WANG L, YU J, NI J, XU XM, WANG J, et al. Extracellular matrix protein 1 (ECM1) is over-expressed in malignant epithelial tumors. Cancer Lett. 2003; 200: 57-67. http://dx.doi.org/10.1016/S0304-3835(03)00350-1
8. KEBEBEW E, PENG M, REIFF E, DUH QY, CLARK OH, et al. ECM1 and TMPRSS4 are diagnostic markers of malignant thyroid neoplasms and improve the accuracy of fine needle aspiration biopsy. Ann Surg. 2005; 242: 353-61.
9. LAL G, HASHIMI S, SMITH BJ, LYNCH CF, ZHANG L, et al. Extracellular Matrix 1(ECM1) expression is a novel prognostic marker for poor long-term survival in breast cancer: a hospital-based cohort study in Iowa[J]. Ann Surg Oncol, 2009; 16: 2280-87. http://dx.doi.org/10.1245/s10434-009-0533-2
10. CHEN H, JIA WD, LI JS, WANG W, XU GL, et al. Extracellular matrix protein 1, a novel prognostic factor, is associated with metastatic potential of hepatocellular carcinoma. Med Oncol. 2010 Dec 3. [Epub ahead of print]
11. ITATSU K, SASAKI M, YAMAGUCHI J, OHIRA S, ISHIKAWA A, et al. Cyclooxygenase-2 Is Involved in the Up-Regulation of Matrix Metalloproteinase-9 in Cholangiocarcinoma Induced by Tumor Necrosis Factor-α. The American Journal of Pathology. 2009; 174: 829-841. http://dx.doi.org/10.2353/ajpath.2009.080012
12. MENAKONGKA A, SUTHIPHONGCHAI T. Involvement of PI3K and ERK1/2 pathways in hepatocyte growth factor-induced cholangiocarcinoma cell invasion. World J Gastroenterol. 2010; 16: 713-722. http://dx.doi.org/10.3748/wjg.v16.i6.713
13. TAN FL, OOI A, HUANG D, WONG JC, QIAN CN, et al. p38delta/MAPK13 as a diagnostic marker for cholangiocarcinoma and its involvement in cell motility and invasion. Int J Cancer. 2010; 126: 2353-61.
14. BRIGGSA CD, NEAL CP, MANNA CD, STEWARD WP, MANSONA MM, et al. Prognostic molecular markers in cholangiocarcinoma: A systematic review. J European of Cancer. 2009; 4: 33-47. http://dx.doi.org/10.1016/j.ejca.2008.08.024
15. MANCINO A, MANCINO MG, GLASER SS, ALPINI G, BOLOGNESE A, et al. Estrogens stimulate the proliferation of human cholangiocarcinoma by inducing the expression and secretion of vascular endothelial growth factor[J]. Dig Liver Dis. 2009; 41: 156-63. http://dx.doi.org/10.1016/j.dld.2008.02.015
16. MONGIAT M, FU J, OLDERSHAW R, GREENHALGH R, GOWN AM, et al. Perlecan protein core interacts with extracellular matrix protein1 (ECM1), a glycoprotein involved in bone formation and angiogenesis. J Biol Chem. 2003; 278: 17491-99. http://dx.doi.org/10.1074/jbc.M210529200
17. FUJIMOTO N, TERLIZZI J, BRITTINGHAM R, FERTALA A, MCGRATH JA, et al. Extracellular matrix protein 1 interacts with the domain III of fibulin-1C and 1D variants through its central tandem repeat 2. Biochem Biophys Res Commun. 2005; 333: 1327-33. http://dx.doi.org/10.1016/j.bbrc.2005.06.046
18. SERCU S, LAMBEIR AM, STEENACKERS E, EL GHALBZOURI A, GEENTJENS K, SASAKI T, et al. ECM1 interacts with fibulin-3 and the beta 3 chain of laminin 332 through its serum albumin subdomain-like 2 domain. Matrix Biol. 2009; 28: 160-169. http://dx.doi.org/10.1016/j.matbio.2009.02.003
19. MCPHERSON L A, WOODFIELD G W, WEIGEL R J. AP2 transcription factors regulate expression of CRABPII in hormone responsive breast carcinoma. J Surg Res. 2007; 138: 71-78. http://dx.doi.org/10.1016/j.jss.2006.07.002
20. KENNY P A, ENVER T, ASHWORTH A. Receptor and secreted targets of Wnt-1/β-catenin signalling in mouse mammary epithelial cells. BMC Cancer. 2005; 5: 3. http://dx.doi.org/10.1186/1471-2407-5-3